$103 Billion is the total value of Baillie Gifford's 701 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
PLAN | Anaplan Inc Common | $98,074,000 | +11.5% | 1,871,644 | 0.0% | 0.10% | -5.0% | |
UBX | Unity Biotechnology Inc | $27,420,000 | +18.2% | 3,803,014 | 0.0% | 0.03% | 0.0% | |
TNDM | Tandem Diabetes Care | $25,912,000 | +1.1% | 434,700 | 0.0% | 0.02% | -13.8% | |
CIB | BanColombia Pref ADRspon adr pref | $14,090,000 | +10.8% | 257,155 | 0.0% | 0.01% | 0.0% | |
SHW | Sherwin-Williams Co | $11,428,000 | +6.1% | 19,584 | 0.0% | 0.01% | -8.3% | |
LIND | Lindblad Expeditions Holdings | $11,445,000 | -2.4% | 700,000 | 0.0% | 0.01% | -15.4% | |
BGT | BlackRock Floating Rate Income | $10,139,000 | +4.9% | 787,770 | 0.0% | 0.01% | -9.1% | |
MRC | MRC Global | $8,866,000 | +12.5% | 650,000 | 0.0% | 0.01% | 0.0% | |
PHD | Pioneer Floating Rate Trust | $5,935,000 | +4.2% | 541,036 | 0.0% | 0.01% | 0.0% | |
NCNA | Nucana Plc ADRsponsored adr | $5,046,000 | -15.7% | 827,308 | 0.0% | 0.01% | -28.6% | |
SINA | SINA Corpord | $5,253,000 | +1.9% | 131,550 | 0.0% | 0.01% | -16.7% | |
HCM | Hutchison China Meditechsponsored adr | $5,463,000 | +40.5% | 217,911 | 0.0% | 0.01% | +25.0% | |
BCRHF | Blue Capital Reinsurance Holdings Fund (USD) | $4,242,000 | -6.9% | 618,438 | 0.0% | 0.00% | -20.0% | |
UXIN | Uxin ADRads | $4,014,000 | -7.7% | 1,776,100 | 0.0% | 0.00% | -20.0% | |
PPR | Voya Prime Rate Trustsh ben int | $3,830,000 | +6.4% | 764,400 | 0.0% | 0.00% | 0.0% | |
JT | Jianpu Technology Inc- ADRadr | $3,107,000 | -40.4% | 2,085,056 | 0.0% | 0.00% | -50.0% | |
SNAP | Snap Inccl a | $3,024,000 | +3.3% | 185,160 | 0.0% | 0.00% | 0.0% | |
TORC | ResTORbio Inc | $1,895,000 | -83.1% | 1,271,387 | 0.0% | 0.00% | -84.6% | |
KLDO | Kaleido Biosciences Inc | $2,208,000 | -33.4% | 440,000 | 0.0% | 0.00% | -50.0% | |
SOHU | Sohu.com | $2,238,000 | +10.1% | 200,140 | 0.0% | 0.00% | 0.0% | |
NSL | Nuveen Senior Income Fund | $2,245,000 | +3.3% | 376,702 | 0.0% | 0.00% | 0.0% | |
APRN | Blue Apron Holdings Inccl a | $977,000 | -22.0% | 148,506 | 0.0% | 0.00% | 0.0% | |
FOMX | Foamix Pharmaceuticals | $730,000 | +9.4% | 219,400 | 0.0% | 0.00% | 0.0% | |
ACTG | Acacia Research Corp | $973,000 | -0.7% | 365,820 | 0.0% | 0.00% | 0.0% | |
TRGP | Targa Resources | $106,000 | +1.9% | 2,599 | 0.0% | 0.00% | – | |
Severstal GDR Reg S | $156,000 | +5.4% | 10,286 | 0.0% | 0.00% | – | ||
NLY | Annaly Capital Man. | $167,000 | +7.1% | 17,762 | 0.0% | 0.00% | – | |
WPM | Wheaton Precious Metals | $158,000 | +13.7% | 5,310 | 0.0% | 0.00% | – | |
ALEC | Alector Inc | $36,000 | +20.0% | 2,072 | 0.0% | 0.00% | – | |
HCAT | Health Catalyst Inc | $86,000 | +8.9% | 2,492 | 0.0% | 0.00% | – | |
MBT | Mobile Telesystems ADRsponsored adr | $214,000 | +25.1% | 21,100 | 0.0% | 0.00% | – | |
SWAV | ShockWave Medical Inc | $39,000 | +44.4% | 891 | 0.0% | 0.00% | – | |
ARI | Apollo Commercial Real Estate Finance REIT | $221,000 | -4.7% | 12,100 | 0.0% | 0.00% | – | |
EW | Edwards Lifesciences Corp | $293,000 | +6.2% | 1,256 | 0.0% | 0.00% | – | |
SAGE | Sage Therapeutics Inc | $35,000 | -49.3% | 490 | 0.0% | 0.00% | – | |
MASI | Masimo Corp | $69,000 | +6.2% | 438 | 0.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-10
About Baillie Gifford
Baillie Gifford is a well-known investment management firm that has been in operation for over a century. The company was founded in 1908 and is headquartered in Edinburgh, Scotland. Baillie Gifford has a reputation for being a long-term investor, with a focus on growth-oriented companies. The firm manages a range of investment strategies, including equities, fixed income, and multi-asset portfolios.
Baillie Gifford has a team of experienced investment professionals, including its CEO, Andrew Telfer, and its Chief Investment Officer, Charles Plowden. The firm's investment philosophy is based on the belief that long-term investing is the best way to achieve superior returns. Baillie Gifford's investment process involves in-depth research and analysis of companies, with a focus on identifying those with strong growth potential.
One of the key strengths of Baillie Gifford is its focus on innovation. The firm has a history of investing in companies that are disrupting traditional industries, such as Tesla and Amazon. Baillie Gifford also has a strong track record of investing in emerging markets, such as China and India.
Overall, Baillie Gifford is a respected investment management firm with a long history of delivering strong returns for its clients. The firm's focus on long-term investing and innovation has helped it to stand out in a crowded market, and its experienced team of investment professionals is well-equipped to navigate the challenges of today's investment landscape.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Amazon.Com | 42 | Q3 2023 | 10.0% |
Tesla Motors | 42 | Q3 2023 | 10.7% |
Illumina | 42 | Q3 2023 | 6.6% |
Baidu.com Sponsored ADR | 42 | Q3 2023 | 11.6% |
Meta Platforms Inc | 42 | Q3 2023 | 5.0% |
MercadoLibre | 42 | Q3 2023 | 7.3% |
Intuitive Surgical | 42 | Q3 2023 | 3.5% |
Moody's Corp | 42 | Q3 2023 | 1.4% |
MasterCard Inc-Class A | 42 | Q3 2023 | 1.9% |
Workday Inc | 42 | Q3 2023 | 1.4% |
View Baillie Gifford's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Oddity Tech Ltd | September 07, 2023 | 4,914,661 | 10.9% |
Roblox Corp | September 07, 2023 | 28,106,215 | 5.0% |
SiteOne Landscape Supply, Inc. | August 03, 2023 | 2,234,985 | 5.0% |
UPWORK, INC | August 03, 2023 | 6,565,230 | 4.9% |
CHINOOK THERAPEUTICS, INC. | August 01, 2023 | 844,684 | 2.0% |
MELI Kaszek Pioneer CorpSold out | July 05, 2023 | 0 | 0.0% |
Abcam plc | June 08, 2023 | 11,331,726 | 4.9% |
CARVANA CO. | June 06, 2023 | 61,989 | 0.1% |
EverQuote, Inc. | May 03, 2023 | 1,358,439 | 5.0% |
CEMEX SAB DE CV | March 03, 2023 | 752,914,110 | 5.0% |
View Baillie Gifford's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G/A | 2024-04-04 |
SC 13G/A | 2024-04-04 |
SC 13G/A | 2024-03-07 |
SC 13G/A | 2024-03-06 |
SC 13G/A | 2024-02-07 |
SC 13G/A | 2024-02-01 |
SC 13G/A | 2024-02-01 |
SC 13G/A | 2024-01-30 |
SC 13G/A | 2024-01-30 |
SC 13G/A | 2024-01-30 |
View Baillie Gifford's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.